Finger prick sampling: the benefits

Our in-house tests (Sanquin Diagnostic Services) for the hospital diagnostic measurements of concentration and antibody response (ADA) of and to biologics in patient serum are now validated for home-monitoring using blood collected via a finger prick.

The benefits

Finger prick testing is available for a wide range of biologics, including natalizumab, adalimumab, infliximab and vedolizumab (both concentration and ADA measurement).
Besides the measurement of biologics, we can measure inflammatory biomarkers to support your clinical decision making. This option will be available soon.
Measuring capillary blood offers more flexibility when to monitor your patient, allowing for swift adjustment of therapy.
You can already have the test result the moment the patient visits you.
Home sampling allows therapeutic drug monitoring with low burdun on your patient.
The patient does not have to visit the hospital or clinic.
The kit is easy to order.
Home sampling is much quicker than routine venous sampling, leading to much faster diagnostics.